AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, F.
Right arrow Articles by Sacchettini, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, F.
Right arrow Articles by Sacchettini, J. C.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, August 2006, p. 2762-2771, Vol. 50, No. 8
0066-4804/06/$08.00+0     doi:10.1128/AAC.00320-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Crystal Structure and Activity Studies of the Mycobacterium tuberculosis ß-Lactamase Reveal Its Critical Role in Resistance to ß-Lactam Antibiotics

Feng Wang,1 Craig Cassidy,2 and James C. Sacchettini1,2*

Department of Biochemistry and Biophysics, Texas A&M University, College Station, Texas 77843,1 Center for Structural Biology, Institute of Biosciences and Technology, Texas A&M University System Health Science Center, Houston, Texas 770302

Received 15 March 2006/ Returned for modification 21 April 2006/ Accepted 6 June 2006

ß-Lactam antibiotics are extremely effective in disrupting the synthesis of the bacterial cell wall in both gram-positive and gram-negative bacteria. However, they are ineffective against Mycobacterium tuberculosis, due to the production of a ß-lactamase enzyme encoded on the chromosome of M. tuberculosis that degrades these antibiotics. Indeed, recent studies have demonstrated that deletion of the blaC gene, the only gene encoding a ß-lactamase in M. tuberculosis, or inhibition of the encoded enzyme resulted in significantly increased sensitivity to ß-lactam antibiotics. In this paper we present a biochemical and structural characterization of M. tuberculosis BlaC. Recombinant BlaC shows a broad range of specificity with almost equal penicillinase and cepholothinase activity. While clavulanate is a mechanism-based inhibitor to class A ß-lactamase with high potency (typically Ki < 0.1 µM), it is a relatively poor inhibitor of the M. tuberculosis BlaC (Ki = 2.4 µM). The crystal structure of the enzyme, determined at a resolution of 1.7 Å, shows that the overall fold of the M. tuberculosis enzyme is similar to other class A ß-lactamases. There are, however, several distinct features of the active site, such as the amino acid substitutions N132G, R164A, R244A, and R276E, that explain the broad specificity of the enzyme, relatively low penicillinase activity, and resistance to clavulanate.


* Corresponding author. Mailing address: Department of Biochemistry and Biophysics, Texas A&M University, College Station, TX 77843. Phone: (979) 862-7636. Fax: (979) 862-7638. E-mail: sacchett{at}tamu.edu.


Antimicrobial Agents and Chemotherapy, August 2006, p. 2762-2771, Vol. 50, No. 8
0066-4804/06/$08.00+0     doi:10.1128/AAC.00320-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2006 by the American Society for Microbiology. All rights reserved.